Basic biological, neurobiological and behavioural research shortlist
Cannaert, A., Storme, J., Franz, F., Auwärter, V., Stove, C.P. (2016), Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. Analytical Chemistry, 88(23): 11476–11485.
Noori, H.R., Linan, A.C., Spanagel, R. (2016), Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: A comprehensive meta-analysis. European Neuropsychopharmacology 26(9): 1419–1430.
Papale, A., Morella, I.M., Indrigo, M.T., Bernardi, R.E., Marrone, L., Marchisella, F., Brancale, A., Spanagel, R., Brambilla, R., Fasano, S. (2016), Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors. eLife, 5:e17111.
Steuer, A.E., Schmidhauser, C., Tingelhoff, E.H., Schmid, Y., Rickli, A., Kraemer, T., Liechti, M.E. (2016), Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans. PLOS ONE 11(3): e0150955.
Population-based and epidemiology research shortlist
Altice, F.L., Azbel, L., Stone, J., Brooks-Pollock, E., Smyrnov, P., Dvoriak, S., Taxman, F.S., El-Bassel, N., Martin, N.K., Booth, R., StÖver, H., Dolan, K., Vickerman, P. (2016), The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. The Lancet 388(10050): 1228–1248.
Carrà, G., Johnson, S., Crocamo, C., Angermeyer, M.C., Brugha, T., Azorin, J., Toumi, M., Bebbington, P.E. (2016), Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe. Psychiatry Research 239: 301–307.
Legleye, S., Khlat, M., Mayet, A., Beck, F., Falissard, B., Chau, N., Peretti-Watel, P. (2016), From cannabis initiation to daily use: educational inequalities in consumption behaviours over three generations in France. Addiction 111(10) 1856–1866.
Raninen, J., Härkönen, J., Landberg, J. (2016), Long-term effects of changes in Swedish alcohol policy: can alcohol policies effective during adolescence impact consumption during adulthood?. Addiction 111(6): 1021–1026.
Taylor, M., Lees, R., Henderson, G., Lingford-Hughes, A., Macleod, J., Sullivan, J., Hickman, M. (2016), Comparison of Cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users. Drug and Alcohol REVIEW 36(2): 220–226.
Markets and drug cultures research shortlist
Soudijn, M., Reuter, P. (2016), Cash and carry: the high cost of currency smuggling in the drug trade. Crime, Law and Social Change 66(3): 271–290.
Pedersen, W., Sandberg, S., Copes, H. (2016), Destruction, fascination and illness: risk perceptions and uses of heroin and opiate maintenance treatment drugs. Health, Risk & Society 19(1-2): 74–79.
Demand reduction intervention research shortlist
Nuijten, M., Blanken, P., Wetering, B., Nuijen, B., Brink, W., Hendriks, V.M. (2016), Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. The Lancet 387(10034): 2226–2234.
Goorden, M., Schee, E., Hendriks, V.M., Roijen, L.H. (2016), Cost-effectiveness of multidimensional family therapy compared to cognitive behavioral therapy for adolescents with a cannabis use disorder: Data from a randomized controlled trial. Drug and Alcohol Dependence 162: 154–161
Hoch, E., Preuss, U.W., Ferri, M., Simon, R. (2016), Digital Interventions for Problematic Cannabis Users in Non-Clinical Settings: Findings from a Systematic Review and Meta-Analysis. European Addiction Research 22(5): 233–242.
Drug policy and suply reduction interventions research shortlist
Berridge, V. (2016), History and the future: Looking back to look forward? International Journal of Drug Policy 37: 117–121.